Report period | 2019 | 2020 | 2021 | 2022 | Q3 23 |
---|---|---|---|---|---|
End date of the reporting period | |||||
Capitalization, $ | |||||
Capitalization, $ | |||||
Enterprise Value | |||||
Book Value | |||||
Shareholders Book Value | |||||
Current liabilities | |||||
Noncurrent liabilities | |||||
Total liabilities | |||||
Debt | |||||
Cash and cash equivalents | |||||
Net debt | |||||
Assets | |||||
Total ordinary shares | |||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
TSVT:US | 2seventy bio | Common share | - | US9013841070 | $4.52 |
Company name | 2seventy bio |
---|---|
Tags | #biotechnology, #cancer treatment |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
Business address | 60 Binney Street Cambridge, MA 02142 United States |
Mailing address | 60 Binney Street Cambridge, MA 02142 United States |
Website | ir.2seventybio.com |